Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer

---

Copy For Citation

Akun E., Okutur K., Seber S., Korkmaz T. , Aydin K., Bozkurt M., ...More

JOURNAL OF BUON, vol.17, no.4, pp.669-676, 2012 (Journal Indexed in SCI)

• Publication Type: Article / Article
• Volume: 17 Issue: 4
• Publication Date: 2012
• Title of Journal : JOURNAL OF BUON
• Page Numbers: pp.669-676

Abstract

Purpose: To determine the clinical features of bevacizumab-associated toxicities in metastatic colorectal cancer (MCRC) patients.